National Health Act 1953 Amendment determination under section 84AF responsible persons (No. PB 126 of 2008) (Cth)

Case

COMMONWEALTH OF AUSTRALIA

Instrument number PB 126 of 2008

Amendment determination under section 84AF of the National Health Act 1953

I, DIANA MACDONELL, Acting Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under section 84AF of the National Health Act 1953.

Dated 3rd DECEMBER    2008

DIANA MACDONELL

Acting Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

Amendment determination – responsible persons

1              Commencement

This instrument commences on 1 January 2009.

2              Amendment of PB 115 of 2008

Schedule 1 amends PB 115 of 2008.

Schedule 1        Amendments

  1. Schedule 1, omit item dealing with Aminoglutethimide

  1. Schedule 1, items dealing with Amiodarone

omit from the columns in the order indicated:

Amiodarone

Tablet containing amiodarone hydrochloride 100 mg

Oral

GenRx Amiodarone

Apotex Pty Ltd

52 096 916 148

  1. Schedule 1, after item dealing with Amoxycillin in the form Capsule 500 mg (as trihydrate) (Amoxil)

insert in  the columns in the order indicated:

Amoxycillin

Capsule 500 mg (as trihydrate)

Oral

Amoxycillin Sandoz

Sandoz Pty Ltd

60 075 449 553

  1. Schedule 1, items dealing with Amoxycillin with Clavulanic Acid

(a)omit from the columns in the order indicated:

Amoxycillin with Clavulanic Acid

Powder for oral suspension containing 125 mg amoxycillin (as trihydrate) with 31.25 mg clavulanic acid (as potassium clavulanate) per 5 mL, 75mL

Oral

Clavulin

GlaxoSmithKline Australia Pty Ltd

47 100 162 481

(b)omit from the columns in the order indicated:

Amoxycillin with Clavulanic Acid

Powder for oral suspension containing 400 mg amoxycillin (as trihydrate) with
57 mg clavulanic acid (as potassium clavulanate) per 5 mL, 60 mL

Oral

Clavulin Duo 400

GlaxoSmithKline Australia Pty Ltd

47 100 162 481

(c)omit from the columns in the order indicated:

Amoxycillin with Clavulanic Acid

Tablet containing
500 mg amoxycillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate)

Oral

Clavulin Duo

GlaxoSmithKline Australia Pty Ltd

47 100 162 481

(d) omit from the columns in the order indicated:

Amoxycillin with Clavulanic Acid

Tablet containing
875 mg amoxycillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate)

Oral

Clavulin Duo Forte

GlaxoSmithKline Australia Pty Ltd

47 100 162 481

  1. Schedule 1, items dealing with Bupropion

omit from the columns in the order indicated:

Bupropion Tablet containing bupropion hydrochloride 150 mg (sustained release) Oral Bupropion-RL GlaxoSmithKline Australia Pty Ltd 47 100 162 481
  1. Schedule 1, items dealing with Captopril

(a) omit from the columns in the order indicated:

Captopril

Tablet 12.5 mg

Oral

Chem mart Captopril

Apotex Pty Ltd

52 096 916 148

(b) omit from the columns in the order indicated:

Captopril

Tablet 12.5 mg

Oral

Terry White Chemists Captopril

Apotex Pty Ltd

52 096 916 148

(c)omit from the columns in the order indicated:

Captopril

Tablet 25 mg

Oral

Chem mart Captopril

Apotex Pty Ltd

52 096 916 148

(d)omit from the columns in the order indicated:

Captopril

Tablet 25 mg

Oral

Terry White Chemists Captopril

Apotex Pty Ltd

52 096 916 148

(e)omit from the columns in the order indicated:

Captopril

Tablet 50 mg

Oral

Chem mart Captopril

Apotex Pty Ltd

52 096 916 148

(f)omit from the columns in the order indicated:

Captopril

Tablet 50 mg

Oral

Terry White Chemists Captopril

Apotex Pty Ltd

52 096 916 148

  1. Schedule 1, after item dealing with Carboplatin in the form Solution for I.V. injection 150 mg in 15 mL (Pfizer Australia Pty Ltd)

insert in the columns in the order indicated:

Carboplatin

Solution for I.V. injection 450 mg in
45 mL

Injection

Baxter Carboplatin

Baxter Healthcare Pty Ltd

43 000 392 781

  1. Schedule 1, after item dealing with Clarithromycin in the form Powder for oral liquid 250 mg per 5 mL, 50 mL

insert in the columns in the order indicated:

Clarithromycin

Tablet 250 mg

Oral

APO-Clarithromycin

Apotex Pty Ltd

52 096 916 148

  1. Schedule 1, item dealing with Cyproheptadine

omit from the columns in the order indicated:

Merck Sharp & Dohme (Australia) Pty Ltd

14 000 173 508

and substitute:

Aspen Pharmacare Australia Pty Limited

51 096 236 985

  1. Schedule 1, after items dealing with Fosinopril

insert in the columns in the order indicated:

Fosinopril with Hydrochlorothiazide

Tablet containing fosinopril sodium
10 mg with hydrochlorothiazide 12.5 mg

Oral

APO-Fosinopril HCTZ 10/12.5

Apotex Pty Ltd

52 096 916 148

  1. Schedule 1, after item dealing with Fosinopril with Hydrochlorothiazide in the form Tablet containing fosinopril sodium 10 mg with hydrochlorothiazide 12.5 mg (Monoplus 10/12.5)

insert in the columns in the order indicated:

Fosinopril with Hydrochlorothiazide

Tablet containing fosinopril sodium
20 mg with hydrochlorothiazide 12.5 mg

Oral

APO-Fosinopril HCTZ 20/12.5

Apotex Pty Ltd

52 096 916 148

Fosinopril with Hydrochlorothiazide

Tablet containing fosinopril sodium
20 mg with hydrochlorothiazide 12.5 mg

Oral

Fosetic 20/12.5

Spirit Pharmaceuticals Pty Ltd

67 109 225 747

  1. Schedule 1, after item dealing with Glucose Indicator─Blood in the form Electrode strips, 50 (Advantage II)

insert in the columns in the order indicated:

Glucose Indicator─Blood

Electrode strips, 50 (FreeStyle)

For external use

FreeStyle

Abbott Australasia Pty Ltd

95 000 180 389

  1. Schedule 1, after items dealing with Hypromellose with Dextran

insert in the columns in the order indicated:

Ibandronic acid

Tablet 50 mg (as ibandronate sodium monohydrate)

Oral

Bondronat

Hospira Pty Limited

13 107 058 328

  1. Schedule 1, items dealing with Indomethacin

omit from the columns in the order indicated (twice occurring):

Merck Sharp & Dohme (Australia) Pty Ltd

14 000 173 508

and substitute:

Aspen Pharmacare Australia Pty Limited

51 096 236 985

  1. Schedule 1, items dealing with Ipratropium

(a) omit from the columns in the order indicated:

Ipratropium

Nebuliser solution containing ipratropium bromide 250 micrograms (anhydrous) in 1 mL single dose units, 30

Inhalation

Chem mart Ipratropium

Apotex Pty Ltd

52 096 916 148

(b) omit from the columns in the order indicated:

Ipratropium

Nebuliser solution containing ipratropium bromide 250 micrograms (anhydrous) in 1 mL single dose units, 30

Inhalation

GenRx Ipratropium

Apotex Pty Ltd

52 096 916 148

(c) omit from the columns in the order indicated:

Ipratropium

Nebuliser solution containing ipratropium bromide 250 micrograms (anhydrous) in 1 mL single dose units, 30

Inhalation

Terry White Chemists Ipratropium

Apotex Pty Ltd

52 096 916 148

(d) omit from the columns in the order indicated:

Ipratropium

Nebuliser solution containing ipratropium bromide
500 micrograms (anhydrous) in 1 mL single dose units, 30

Inhalation

Chem mart Ipratropium

Apotex Pty Ltd

52 096 916 148

(e) omit from the columns in the order indicated:

Ipratropium

Nebuliser solution containing ipratropium bromide
500 micrograms (anhydrous) in 1 mL single dose units, 30

Inhalation

GenRx Ipratropium

Apotex Pty Ltd

52 096 916 148

(f) omit from the columns in the order indicated:

Ipratropium

Nebuliser solution containing ipratropium bromide
500 micrograms (anhydrous) in 1 mL single dose units, 30

Inhalation

Terry White Chemists Ipratropium

Apotex Pty Ltd

52 096 916 148

  1. Schedule 1, after item dealing with Ipratropium in the form Nebuliser solution containing ipratropium bromide 250 micrograms (anhydrous) in 1 mL single dose units, 30 (Apoven 250)

insert in the columns in the order indicated:

Ipratropium

Nebuliser solution containing ipratropium bromide
250 micrograms (anhydrous) in 1 mL single dose units, 30

Inhalation

APO-Ipratropium

Apotex Pty Ltd

52 096 916 148

  1. Schedule 1, after item dealing with Ipratropium in the form Nebuliser solution containing ipratropium bromide 500 micrograms (anhydrous) in 1 mL single dose units, 30 (Apoven 500)

insert in the columns in the order indicated:

Ipratropium

Nebuliser solution containing ipratropium bromide
500 micrograms (anhydrous) in 1 mL single dose units, 30

Inhalation

APO-Ipratropium

Apotex Pty Ltd

52 096 916 148

  1. Schedule 1, item dealing with Isotretinoin

omit from the columns in the order indicated:

Isotretinoin

Capsule 10 mg

Oral

GenRx Isotretinoin

Apotex Pty Ltd

52 096 916 148

  1. Schedule 1, items dealing with Lamotrigine

(a) omit from the columns in the order indicated:

Lamotrigine

Tablet 100 mg

Oral

Elmendos

GlaxoSmithKline Australia Pty Ltd

47 100 162 481

(b) omit from the columns in the order indicated:

Lamotrigine

Tablet 100 mg

Oral

Lamitrin

Sandoz Pty Ltd

60 075 449 553

(c) omit from the columns in the order indicated:

Lamotrigine

Tablet 200 mg

Oral

Elmendos

GlaxoSmithKline Australia Pty Ltd

47 100 162 481

(d) omit from the columns in the order indicated:

Lamotrigine

Tablet 200 mg

Oral

Lamitrin

Sandoz Pty Ltd

60 075 449 553

(e) omit from the columns in the order indicated:

Lamotrigine

Tablet 25 mg

Oral

Elmendos

GlaxoSmithKline Australia Pty Ltd

47 100 162 481

(f) omit from the columns in the order indicated:

Lamotrigine

Tablet 25 mg

Oral

Lamitrin

Sandoz Pty Ltd

60 075 449 553

(g) omit from the columns in the order indicated:

Lamotrigine

Tablet 5 mg

Oral

Elmendos

GlaxoSmithKline Australia Pty Ltd

47 100 162 481

(h) omit from the columns in the order indicated:

Lamotrigine

Tablet 5 mg

Oral

Lamitrin

Sandoz Pty Ltd

60 075 449 553

(i) omit from the columns in the order indicated:

Lamotrigine

Tablet 50 mg

Oral

Elmendos

GlaxoSmithKline Australia Pty Ltd

47 100 162 481

(j) omit from the columns in the order indicated:

Lamotrigine

Tablet 50 mg

Oral

Lamitrin

Sandoz Pty Ltd

60 075 449 553

  1. Schedule 1, item dealing with Metformin in the form Tablet containing metformin hydrochloride 500 mg (extended release)

omit from the column headed “Form”:

Tablet containing metformin hydrochloride 500 mg (extended release)

and substitute:

Tablet (extended release) containing metformin hydrochloride 500 mg

  1. Schedule 1, after item dealing with Metformin in the form Tablet (extended release) containing metformin hydrochloride 500 mg

insert in the columns in the order indicated:

Metformin

Tablet (extended release) containing metformin hydrochloride 500 mg

Oral

Metex XR

Sigma Pharmaceuticals (Australia) Pty Ltd

88 004 118 594

  1. Schedule 1, item dealing with Methyldopa in the form Tablet 250 mg (Aldomet)

omit from the columns in the order indicated:

Merck Sharp & Dohme (Australia) Pty Ltd

14 000 173 508

and substitute:

Aspen Pharmacare Australia Pty Limited

51 096 236 985

  1. Schedule 1, after item dealing with Mirtazapine in the form Tablet
    30 mg (orally disintegrating)

insert in the columns in the order indicated:

Mirtazapine

Tablet 45 mg

Oral

APO-Mirtazapine

Apotex Pty Ltd

52 096 916 148

  1. Schedule 1, after item dealing with Mirtazapine in the form Tablet
    45 mg (Avanza)

insert in the columns in the order indicated:

Mirtazapine

Tablet 45 mg

Oral

Chem mart Mirtazapine

Apotex Pty Ltd

52 096 916 148

  1. Schedule 1, after item dealing with Mirtazapine in the form Tablet
    45 mg (Mirtazon)

insert in the columns in the order indicated:

Mirtazapine

Tablet 45 mg

Oral

Terry White Chemists Mirtazapine

Apotex Pty Ltd

52 096 916 148

  1. Schedule 1, items dealing with Nifedipine

(a) omit from the columns in the order indicated:

Nifedipine

Tablet 20 mg

Oral

Chem mart Nifedipine

Apotex Pty Ltd

52 096 916 148

(b) omit from the columns in the order indicated:

Nifedipine

Tablet 20 mg

Oral

Terry White Chemists Nifedipine

Apotex Pty Ltd

52 096 916 148

  1. Schedule 1, item dealing with Paclitaxel in the forms Solution concentrate for I.V. infusion 30 mg in 5 mL vial, Solution concentrate for I.V. infusion 100 mg in 16.7 mL vial, Solution concentrate for I.V. infusion 150 mg in 25 mL vial and Solution concentrate for I.V. infusion 300 mg in 50 mL vial

omit from the column headed “Form”:

vial

  1. Schedule 1, after item dealing with Paclitaxel in the form Solution concentrate for I.V. infusion 100 mg in 16.7 mL (Anzatax)

insert in the columns in the order indicated:

Paclitaxel

Solution concentrate for I.V. infusion 100 mg in 16.7 mL

Injection

Baxter Paclitaxel

Baxter Healthcare Pty Ltd

43 000 392 781

  1. Schedule 1, after item dealing with Paclitaxel in the form Solution concentrate for I.V. infusion 30 mg in 5 mL (Anzatax)

insert in the columns in the order indicated:

Paclitaxel

Solution concentrate for I.V. infusion 30 mg in 5 mL

Injection

Baxter Paclitaxel

Baxter Healthcare Pty Ltd

43 000 392 781

  1. Schedule 1, after item dealing with Paclitaxel in the form Solution concentrate for I.V. infusion 300 mg in 50 mL (Anzatax)

insert in the columns in the order indicated:

Paclitaxel

Solution concentrate for I.V. infusion 300 mg in 50 mL

Injection

Baxter Paclitaxel

Baxter Healthcare Pty Ltd

43 000 392 781

  1. Schedule 1, items dealing with Paracetamol

omit from the columns in the order indicated:

Paracetamol

Tablet 500 mg

Oral

Tylenol

Johnson & Johnson Pacific Pty Limited

73 001 121 446

  1. Schedule 1, omit items dealing with Piperazine Oestrone

  1. Schedule 1, items dealing with Piroxicam

(a) omit from the columns in the order indicated:

Piroxicam

Dispersible tablet
10 mg

Oral

GenRx Piroxicam Dispersible

Apotex Pty Ltd

52 096 916 148

(b) omit from the columns in the order indicated:

Piroxicam

Dispersible tablet
20 mg

Oral

Chem mart Piroxicam Dispersible

Apotex Pty Ltd

52 096 916 148

(c) omit from the columns in the order indicated:

Piroxicam

Dispersible tablet
20 mg

Oral

GenRx Piroxicam Dispersible

Apotex Pty Ltd

52 096 916 148

(d) omit from the columns in the order indicated:

Piroxicam

Dispersible tablet
20 mg

Oral

Terry White Chemists Piroxicam Dispersible

Apotex Pty Ltd

52 096 916 148

  1. Schedule 1, after items dealing with Polyvinyl Alcohol

insert in the columns in the order indicated:

Posaconazole

Oral suspension 40 mg per mL, 105 mL

Oral

Noxafil

Schering-Plough Pty Limited

57 000 235 245

  1. Schedule 1, after item dealing with Pravastatin in the form Tablet containing pravastatin sodium 40 mg (Vastorin)

insert in the columns in the order indicated:

Pravastatin

Tablet containing pravastatin sodium
80 mg

Oral

APO-Pravastatin

Apotex Pty Ltd

52 096 916 148

Pravastatin

Tablet containing pravastatin sodium
80 mg

Oral

Chem mart Pravastatin

Apotex Pty Ltd

52 096 916 148

  1. Schedule 1, after item dealing with Pravastatin in the form Tablet containing pravastatin sodium 80 mg (Pravastatin-GA 80)

insert in the columns in the order indicated:

Pravastatin

Tablet containing pravastatin sodium
80 mg

Oral

Terry White Chemists Pravastatin

Apotex Pty Ltd

52 096 916 148

  1. Schedule 1, items dealing with Salbutamol

(a) omit from the columns in the order indicated:

Salbutamol

Nebuliser solution
2.5 mg (as sulfate) in 2.5 mL single dose units, 30

Inhalation

Chem mart Salbutamol

Apotex Pty Ltd

52 096 916 148

(b) omit from the columns in the order indicated:

Salbutamol

Nebuliser solution
2.5 mg (as sulfate) in 2.5 mL single dose units, 30

Inhalation

Terry White Chemists Salbutamol

Apotex Pty Ltd

52 096 916 148

(c)omit from the columns in the order indicated:

Salbutamol

Nebuliser solution
5 mg (as sulfate) in
2.5 mL single dose units, 30

Inhalation

Chem mart Salbutamol

Apotex Pty Ltd

52 096 916 148

(d)omit from the columns in the order indicated:

Salbutamol

Nebuliser solution
5 mg (as sulfate) in
2.5 mL single dose units, 30

Inhalation

Terry White Chemists Salbutamol

Apotex Pty Ltd

52 096 916 148

  1. Schedule 1, items dealing with Sumatriptan

omit from the columns in the order indicated:

Sumatriptan

Tablet 50 mg (as succinate)

Oral

Suvalan 50

GlaxoSmithKline Australia Pty Ltd

47 100 162 481

  1. Schedule 1, items dealing with Tamoxifen

omit from the columns in the order indicated:

Tamoxifen

Tablet 10 mg (as citrate)

Oral

Nolvadex

AstraZeneca Pty Ltd

54 009 682 311

  1. Schedule 1, after item dealing with Temozolomide in the form Capsule 100 mg

insert in the columns in the order indicated:

Temozolomide

Capsule 140 mg

Oral

Temodal

Schering-Plough Pty Limited

57 000 235 245

  1. Schedule 1, items dealing with Trimethoprim with Sulfamethoxazole

(a) omit from the columns in the order indicated:

Trimethoprim with Sulfamethoxazole

Tablet 160 mg-800 mg

Oral

Chem mart Trimethoprim with Sulfamethoxazole DS

Apotex Pty Ltd

52 096 916 148

(b) omit from the columns in the order indicated:

Trimethoprim with Sulfamethoxazole

Tablet 160 mg-800 mg

Oral

GenRx Trimethoprim with SulfamethoxazoleDS

Apotex Pty Ltd

52 096 916 148

(c) omit from the columns in the order indicated:

Trimethoprim with Sulfamethoxazole

Tablet 160 mg-800 mg

Oral

Terry White Chemists Trimethoprim with SulfamethoxazoleDS

Apotex Pty Ltd

52 096 916 148

Actions
Download as PDF Download as Word Document


Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0